Abstract
This cross-sectional study assesses quarterly trends in glucagon-like peptide-1 receptor agonist prescribing and metabolic and bariatric surgery use among adolescents eligible for metabolic and bariatric surgery.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureJohn B. Rode, Thomas H. Inge, Allan D. Wu, Caren Mangarelli, Justin R. Ryder
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Prevalence of extremely severe obesity and metabolic dysfunction among US children and adolescents.
10.1001/jamanetworkopen.2025.21170 · 2025
Ten-year outcomes after bariatric surgery in adolescents.
10.1056/nejmc2404054 · 2024
Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity.
10.1542/peds.2022-060640 · 2023
2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for metabolic and bariatric surgery.
10.1016/j.soard.2022.08.013 · 2022
Trends in metabolic and bariatric surgery use during the GLP-1 receptor agonist era.
10.1001/jamasurg.2026.0049 · 2026
No additional external references are available.